Video Resources

Discover the latest in immuno-oncology: Overcoming traditional TCR gene expression limits using mRNA for rapid, cost-effective candidate screening. Learn how automation in synthetic biology enhances adoptive T-cell therapies and vaccine discovery.

Tune into this on-demand webinar for an exploration of Telesis Bio's innovative BioXp® platform and SOLA DNA synthesis technology. Learn how these tools are redefining the landscape of synthetic and molecular biology, accelerating the pace of discovery and therapeutic development.

Watch this on-demand webinar to gain in-depth knowledge about the mRNA synthesis solutions powered by the BioXp, including the differences and applications of mRNA De novo and mRNA Select Synthesis kits.

In this presentation, learn how Telesis Bio’s automated BioXp synthetic biology solutions are designed to help you break free from traditional lead synthesis bottlenecks and significantly accelerate your antibody discovery pipeline.

Join us for our recorded webinar presented at SynBiobeta 2023 to explore Telesis Bio's BioXp platform for automating molecular biology workflows in synthetic biology and multiomic applications.

Join us for our recorded webinar presented at SynBioBeta 2023 to explore the groundbreaking potential of synthetic biology in advancing mRNA-based vaccines. Discover how Telesis Bio addresses the bottlenecks in vaccine discovery.

Long lead times for mRNA synthesis can create a bottleneck to advancing discovery and maximizing the potential of mRNA-based vaccines and therapeutics. In this presentation, Dr. Kannan highlights the challenges of current mRNA synthesis workflows...

In this talk sponsored by Telesis Bio, Dr. David Brown, Associate Director, R&D at RNAimmune presents an intro into the key technology, tools and knowhow driving their mRNA vaccine development programs. He describes how their team utilized the BioXp® system....

Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 genome — the causal agent of COVID-19 — using a commercially available, automated DNA assembly and cloning instrument — the BioXp™ system...

In an industry facing increasingly challenging deliverables, the ability to rapidly build synthetic DNA, mRNA, and protein is critical. Imagine an antibody development pipeline...

In this video, Dr. Shen, discusses the application of the BioXp technology that was key to accelerating RNAimmune’s vaccine discovery process for the KRAS vaccine. The presentation is focused on RNAimmune’s cancer vaccine discovery platform...

In this webinar, speakers Dr. Krishna Kannan and Dr. Silvi Rouskin bring decades of experience in synthetic biology and viral research, blending the 2 topics in a seamless way...

The success of mRNA-based COVID-19 vaccines has resulted in increased opportunity for advancing mRNA as a platform for vaccine and therapeutic discovery...

If your discovery program is limited by the speed of your capabilities in synthesis and cloning of lead candidates, you’re not alone. Learn how Telesis Bio’s hands-free automated BioXp® synthetic biology solutions...

In this presentation, you will learn how to construct synthesis is a bottleneck in antibody therapeutic development...

In this webinar, Dr. Elisa Marques from Telesis Bio will provide an overview of the latest synthetic biology solutions for metabolic pathway and enzyme engineering and how these can be used to improve discovery processes...